Langheinrich, M.; Siebenhüner, A.R.; Baecker, J.; Miragall, M.; Wiesmüller, F.; Schellerer, V.; Merkel, S.; Brunner, M.; Krautz, C.; Weber, K.;
et al. NCR, an Inflammation and Nutrition Related Blood-Based Marker in Colon Cancer Patients: A New Promising Biomarker to Predict Outcome. Diagnostics 2023, 13, 116.
https://doi.org/10.3390/diagnostics13010116
AMA Style
Langheinrich M, Siebenhüner AR, Baecker J, Miragall M, Wiesmüller F, Schellerer V, Merkel S, Brunner M, Krautz C, Weber K,
et al. NCR, an Inflammation and Nutrition Related Blood-Based Marker in Colon Cancer Patients: A New Promising Biomarker to Predict Outcome. Diagnostics. 2023; 13(1):116.
https://doi.org/10.3390/diagnostics13010116
Chicago/Turabian Style
Langheinrich, Melanie, Alexander Reinhard Siebenhüner, Justus Baecker, Maximilian Miragall, Felix Wiesmüller, Vera Schellerer, Susanne Merkel, Maximilian Brunner, Christian Krautz, Klaus Weber,
and et al. 2023. "NCR, an Inflammation and Nutrition Related Blood-Based Marker in Colon Cancer Patients: A New Promising Biomarker to Predict Outcome" Diagnostics 13, no. 1: 116.
https://doi.org/10.3390/diagnostics13010116
APA Style
Langheinrich, M., Siebenhüner, A. R., Baecker, J., Miragall, M., Wiesmüller, F., Schellerer, V., Merkel, S., Brunner, M., Krautz, C., Weber, K., Grützmann, R., & Kersting, S.
(2023). NCR, an Inflammation and Nutrition Related Blood-Based Marker in Colon Cancer Patients: A New Promising Biomarker to Predict Outcome. Diagnostics, 13(1), 116.
https://doi.org/10.3390/diagnostics13010116
